ICS/ICB leaders Penny Dash and Paul Miller announced as speakers for the NHS Transformation Symposium

Mtech Access are delighted to announce that their annual NHS Transformation Symposium, this September, will feature guest speakers Penny Dash and Paul Miller, who hold strategic leadership roles in an Integrated Care System (ICS) and Board (ICB), respectively.

Each year, Mtech Access invite UK market access and commercialisation teams from Pharma and MedTech companies to join guest speakers from across the NHS at their NHS Symposium. This year, the NHS Transformation Symposium will take place on Tuesday 26th September at the Hallam Conference Centre, London.

The agenda includes keynote addresses and interviews with:

• Dr Penny Dash (Chair of North West London ICS)
• Paul Miller (Non-Executive Director [NED], North East Somerset, Swindon and Wiltshire ICB and NED, Salisbury NHS Foundation Trust)
• An ICB board member with a background in transformation, strategy and economics (TBA)

There will also be a panel discussion, led by Paul Miller, and featuring guest speakers:

• George Coxon (Chair of the South West Care Collaborative)
• Crystal Dennis (Head of Digital Access to Services, Dorset ICS)
• Regional cancer lead (TBA)

In the afternoon, attendees will choose from one of three practical breakout sessions, each featuring one of our panellists:

1. Collaborating with the NHS – How to become the irresistible ingredient
2. Advances and trends in digital care at home
3. Challenges for oncology and other complex conditions

Mtech Access invite market access teams from Pharmaceutical and MedTech companies to join us for this event. Early bird tickets cost just £145 per person (+VAT and booking fee) and are available until Tuesday 15th August.

Learn more about this event at: https://mtechaccess.co.uk/nhs-transformation-symposium-2023/

Book tickets now at: https://www.eventbrite.co.uk/e/nhs-transformation-symposium-for-pharma-and-medtech-tickets-672048193237 

About Mtech Access:

Mtech Access’ mission is to ensure that medical technologies are available to the patients who need them, whilst meeting the needs of the healthcare environment. As market access specialists, they work in expert-led partnerships with innovators across the healthcare sector, providing commercialisation strategy, evidence synthesis and analysis, and value demonstration services. The team draw on insights from over 100+ NHS Associates, who guide and validate their work.